DEC TIMOTHY C
SEC insider (Form 3/4/5 filer). CIK 0001194020. Senior Vice-President & CFO at SUPERNUS PHARMACEUTICALS, INC. (SUPN). 41 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in ROCKVILLE, MD.
Companies DEC TIMOTHY C has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Officer, Senior Vice-President & CFO
DEC TIMOTHY C
CIK: 0001194020
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SUPERNUS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (41 total)
- Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect1.3K shares- - Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect604 shares at avg. $46.57$28K - Jul 29, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectPerformance Share Unit
1.3K shares- - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect3K shares- - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect3K shares- - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect1.5K shares at avg. $54.73$79K - Mar 6, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect1.4K shares at avg. $54.73$78K - Feb 28, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectPerformance Share Unit
3K shares- - Feb 28, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectPerformance Share Unit
3K shares- - Feb 25, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect1.3K shares at avg. $50.69$65K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 1,250 | - | $0 | Direct |
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 604 | $46.57 | $28,128 | Direct |
| Jul 29, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Performance Share Unit | 1,250 | - | - | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 3,000 | - | $0 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 3,000 | - | $0 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 1,450 | $54.73 | $79,359 | Direct |
| Mar 6, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 1,433 | $54.73 | $78,428 | Direct |
| Feb 28, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Performance Share Unit | 3,000 | - | - | Direct |
| Feb 28, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Performance Share Unit | 3,000 | - | - | Direct |
| Feb 25, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 1,279 | $50.69 | $64,833 | Direct |
1-10 of 41 transactions